A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.
Also called NCT01305824
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 151 participants
- Sponsor
- Registry
-
NCT01305824
-
- Other papers using this trial's data
- Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01305824. Randomized; quadruple masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2012-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
- Condition
- Chronic Kidney Disease
- Intervention (Drug)
- PRT-201
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- PRT-201
- Lead sponsor
- Proteon Therapeutics
Record details
- Record id
cardio:ct-nct01305824- Content hash
a4533f384607e4873672aafa769533ffda5523c9a46415cf080df3a1fe50603b